Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults with Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results from the Phase 3 CHAMPION MG Open-label Extension

              Author:Vu, Tuan   Mantegazza, Renato   Annane, Djillali   Katsuno, Masahisa   Meisel, Andreas   Nicolle, Michael   Bril, Vera   Aguzzi, Rasha   Frick, Glen   Howard, James   

              Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S15.010  

              Author Institution:University of South Florida Morsani College of Medicine, Tampa, FL  Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy  Hôpital Raymond Poincaré, Garches, France  Nagoya University Graduate School of Medicine, Nagoya, Japan  Charité Universitätsmedizin Berlin, Berlin, Germany  London Health Sciences Centre, London, ON, Canada  University of Toronto, Toronto, ON, Canada  Alexion, AstraZeneca Rare Disease, Boston, MA  The University of North Carolina, Chapel Hill, NC